Literature DB >> 12377287

Protein kinases as drug targets in parasitic protozoa.

Christian Doerig1, Laurent Meijer, Jeremy C Mottram.   

Abstract

The importance of protein kinases in cell signaling and cell cycle control has led to detailed structural and functional studies in various eukaryotes, and hence to the synthesis of specific chemical inhibitors for managing disease. Here, the current progress in applying developments from the wider protein kinase field to parasitic protozoa is reviewed. The availability of genome sequence data for several parasites has led to the identification of many protein kinases. Reverse genetics studies, including gene knockout and 'chemical genetics', can help to define the roles of the protein kinases and validate them as drug targets. In addition, screening chemical libraries with active recombinant protein kinases can identify lead compounds for drug design.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377287     DOI: 10.1016/s1471-4922(02)02321-8

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  21 in total

1.  The role of two novel regulatory sites in the activation of the cGMP-dependent protein kinase from Plasmodium falciparum.

Authors:  Wensheng Deng; Asha Parbhu-Patel; David J Meyer; David A Baker
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 2.  Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.

Authors:  Wim G J Hol
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-16       Impact factor: 1.056

3.  Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite.

Authors:  Yimin Wu; Xiangyun Wang; Xia Liu; Yufeng Wang
Journal:  Genome Res       Date:  2003-04       Impact factor: 9.043

4.  Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.

Authors:  G Gargala; A Baishanbo; L Favennec; A François; J J Ballet; J-F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Molecular models of protein kinase 6 from Plasmodium falciparum.

Authors:  Karisa Karla Manhani; Helen Andrade Arcuri; Nelson José Freitas da Silveira; Hugo Brandão Uchôa; Walter Filgueira de Azevedo; Fernanda Canduri
Journal:  J Mol Model       Date:  2005-11-04       Impact factor: 1.810

Review 6.  Proteomics of the human malaria parasite Plasmodium falciparum.

Authors:  Paul F G Sims; John E Hyde
Journal:  Expert Rev Proteomics       Date:  2006-02       Impact factor: 3.940

7.  A novel protein phosphatase 2A (PP2A) is involved in the transformation of human protozoan parasite Trypanosoma cruzi.

Authors:  Jorge González; Alberto Cornejo; Marcia R M Santos; Esteban M Cordero; Bessy Gutiérrez; Patricio Porcile; Renato A Mortara; Hernán Sagua; José Franco Da Silveira; Jorge E Araya
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

8.  The Entamoeba histolytica serum-inducible transmembrane kinase EhTMKB1-9 is involved in intestinal amebiasis.

Authors:  Mayuresh M Abhyankar; Shiteshu Shrimal; Carol A Gilchrist; Alok Bhattacharya; William A Petri
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-12       Impact factor: 4.077

9.  2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities.

Authors:  Boris Rodenko; Alida M van der Burg; Martin J Wanner; Marcel Kaiser; Reto Brun; Matthew Gould; Harry P de Koning; Gerrit-Jan Koomen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

Review 10.  Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

Authors:  Lucio H Freitas-Junior; Eric Chatelain; Helena Andrade Kim; Jair L Siqueira-Neto
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-28       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.